RADAR-base platform launched

A team based at King’s College London, in close collaboration with The Hyve and other members of RADAR-CNS Technical Platforms team (WP7), have designed a new remote platform, called RADAR-base.

For researchers RADAR-base enables remote streaming data collection, secure data transmission and scalable solutions for data storage, management and access.

It allows study participants to share their health data (e.g. from sensors and questionnaires) with clinicians and researchers in a secure way, keeping identifiable data local while linking to other non-identifiable data centrally.

RADAR-base was created to meet RADAR-CNS project requirements which are delivered through a microservices architecture. It has been released under an open source Apache 2 licence so it is able to be used by the wider mHealth community.

The RADAR-base platform is applicable to a wide range of health and disease areas, allowing use cases from a healthy lifestyle to prevent and pre-empt pathologies to relapse prediction and medical interventions.  

King’s College London’s Dr Amos Folarin, part of the RADAR-CNS Technical Platforms team and RADAR-base project lead, said, ‘RADAR-base provides an exciting, unique opportunity to empower research with data from both medical-grade and consumer-grade devices. RADAR-base gives researchers and device manufacturers a place to build open systems to share, manage, host, and actually use these data to support the next generation of healthcare.’

Kees van Bochove, CEO at The Hyve, said, ‘Digital Biomarkers is a highly active field, and one of the most promising contenders along with genomics and imaging to implement precision medicine and improve health outcomes. The RADAR-base platform is the first fully scalable and secure open source IoT platform for real-time remote sensor data collection in the context of clinical studies with wearable devices. It fills a great need for a pre-competitive platform which can be used by device vendors, CROs, and researchers from academia and pharma companies to execute these trials.'

Dr Faith Matcham, King’s College London from WP6 said, ‘We’re using RADAR-base for the RADAR-CNS study in major depression. Our participants aren’t in a hospital setting, so data is collected as part of their daily lives. Besides the sensor data from smartphones and wearables devices, participants also answer questionnaires via the RADAR-CNS app, which provides information about their mood, social environment, stress, and daily activities. We also use the RADAR-CNS questionnaire app to collect a couple of validated measures of depression and self-esteem.’

For more information, please visit the website www.radar-base.org and the confluence wiki documentation https://radar-base.atlassian.net/wiki